Endocrinology

A new category of cardiovascular “extreme risk” has LDL-C goals of

In terms of specific endocrine functions, bones favor glucose metabolism and homeostasis and are necessary for memory formation and for muscle function during exercise. Gerard Karsenty, MD, PhD also explained that osteo-calcium is not only necessary to foster this function, but it’s also sufficient, and can improve this function in animals.

More research and education could to prevent inherent risks

Larry Altstiel, MD, PhD, EVP, Chief Medical Officer, vTv Therapeutics also discussed their team’s programs in type 2 diabetes. One is an activator of an enzyme called glucocynase – a master regulator for glucose in the body. According to Altstiel, when glucose is too high, it either shuns it off to energy production or stores it in the form of glycogen. It’s an insulin independent way of how the body controls glucose.

The team approach allows for more eyes on the patient, so more information can be gathered to help pinpoint any barriers to care.

Praluent can help patients with clinical ASCVD or HeFH

For the first time, the WHO has prequalified a generic API for treating HCV.

Could insulin could be dosed off of values from a continuous glucose monitor? Anne Peters, MD, and team sought to find out.

A project from the University of New Mexico looks to turn physicians to experts.

Could corticosteroid use put your patients at a greater risk of metabolic syndrome?

Bradley Miller, MD, University of Minnesota Academic Health Center hopes the team learns “good information” about how kids are growing on this dose of somavaratan that will then be confirmed in the phase 3 head-to-head with growth hormone daily.

Changes in adolescent brain structure are potentially associated with the onset of mental health disorders.

Men’s health studies presented at ENDO 2017 included a possible prostate cancer treatment and the potential of hormone therapy to prevent frailty.

Researchers sought to discover the specific physiological pathways of fibroblast growth factor 21.